Towards the discovery of drug-like epigallocatechin gallate analogs as Hsp90 inhibitors.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2014-05-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2014.03.088PMID 24745965
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correlation between chemotype-dependent binding conformations of HSP90α/β and isoform selectivity-Implications for the structure-based design of HSP90α/β selective inhibitors for treating neurodegenerative diseases.

  2014cited by this paper
• Anti‐infective properties of epigallocatechin‐3‐gallate (EGCG), a component of green tea

  2013cited by this paper
• Synthesis and structure-activity relationships of EGCG analogues, a recently identified Hsp90 inhibitor.

  2013cited by this paper
• Redox chemistry of green tea polyphenols: therapeutic benefits in neurodegenerative diseases.

  2012cited by this paper
• Synthesis and antimalarial evaluation of novel benzopyrano[4,3-b]benzopyran derivatives.

  2011cited by this paper
• (-)-Epigallocatechin-3-gallate is a novel Hsp90 inhibitor.

  2009cited by this paper
• The challenge of developing green tea polyphenols as therapeutic agents

  2008cited by this paper
• A para-amino substituent on the D-ring of green tea polyphenol epigallocatechin-3-gallate as a novel proteasome inhibitor and cancer cell apoptosis inducer.

  2007cited by this paper
• Search for Hsp90 inhibitors with potential anticancer activity: isolation and SAR studies of radicicol and monocillin I from two plant-associated fungi of the Sonoran desert.

  2006cited by this paper
• Structure-activity relationships of synthetic analogs of (-)-epigallocatechin-3-gallate as proteasome inhibitors.

  2004cited by this paper
• 17AAG: low target binding affinity and potent cell activity--finding an explanation.

  2003cited by this paper
• Epimerization of tea catechins and O-methylated derivatives of (-)-epigallocatechin-3-O-gallate: relationship between epimerization and chemical structure.

  2003cited by this paper

• Hydrogel design to overcome thermal resistance and ROS detoxification in photothermal and photodynamic therapy of cancer.

  2023cites this paper
• Tea-break with epigallocatechin gallate derivatives - Powerful polyphenols of great potential for medicine.

  2023cites this paper
• Nanomaterial-mediated low-temperature photothermal therapy via heat shock protein inhibition

  2022cites this paper
• Functionalized Chromans from ortho-Quinone Methides and Arylallenes.

  2022cites this paper
• Lanthanide nanoparticles for near-infrared II theranostics

  2022cites this paper
• Ebola Entry Inhibitors Discovered from Maesa perlarius

  2022cites this paper
• Intramolecular N-Me and N-H aminoetherification for the synthesis of N-unprotected 3-amino-O-heterocycles.

  2021cites this paper
• Metal-phenolic networks for cancer theranostics.

  2021cites this paper
• Tumor Acidity and Near‐Infrared Light Responsive Dual Drug Delivery Polydopamine‐Based Nanoparticles for Chemo‐Photothermal Therapy

  2021cites this paper
• Antibacterial activity of Barbatimão (Stryphnodendron adstringens) against Staphylococcus aureus: in vitro and in silico studies.

  2020cites this paper
• Heat shock protein 90 (Hsp90) Inhibitors: An Update on Achievements, Challenges, and Future Directions.

  2020cites this paper
• Recent progress in NIR-II emitting lanthanide-based nanoparticles and their biological applications

  2020cites this paper
• Application of Dess-Martin oxidation in total synthesis of natural products.

  2020cites this paper
• C-terminal modulators of heat shock protein of 90 kDa (HSP90): State of development and modes of action.

  2019cites this paper
• Biocompatible Heat-Shock Protein Inhibitor-Delivered Flowerlike Short-Wave Infrared Nanoprobe for Mild Temperature-Driven Highly Efficient Tumor Ablation.

  2019cites this paper
• HSP90 Inhibitors Blocking Multiple Oncogenic Signaling Pathways for the Treatment of Cancer

  2019cites this paper
• Expression, purification, and inhibition profile of dihydrofolate reductase from the filarial nematode Wuchereria bancrofti

  2018cites this paper
• Catechin-Modified Polylactide Stereocomplex at Chain End Improved Antibiobacterial Property.

  2016cites this paper
• Novel and less explored chemotypes of natural origin for the inhibition of Hsp90

  2016cites this paper
• The Hsp90 Chaperone Machinery: An Important Hub in Protein Interaction Networks.

  2016cites this paper
• The Heat Shock Protein 90 Inhibitor, (−)-Epigallocatechin Gallate, Has Anticancer Activity in a Novel Human Prostate Cancer Progression Model

  2015cites this paper
• Structure-activity studies of (-)-epigallocatechin gallate derivatives as HCV entry inhibitors.

  2014cites this paper